Related Experiment Video

Updated: May 25, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Intravenous thrombolysis is more effective in ischemic cardioembolic strokes than in non-cardioembolic?

Sofia Rocha1, Arnaldo Pires, Joana Gomes

  • 1Neurology Department, Braga Hospital, Portugal. sofiar@ufp.edu.pt

Arquivos De Neuro-Psiquiatria
|February 3, 2012
PubMed

Insights

Intravenous thrombolysis (IT) showed no significant clinical benefit in cardioembolic (CE) stroke compared to non-cardioembolic (NCE) stroke. Outcomes were similar between groups, suggesting IT may not be specifically beneficial for CE stroke patients.

Area of Science:

  • Neurology
  • Cardiology
  • Emergency Medicine

Background:

  • Intravenous thrombolysis (IT) is a critical treatment for acute ischemic stroke.
  • Previous studies suggested potential benefits of IT in cardioembolic (CE) stroke due to larger recanalization extent.

Purpose of the Study:

  • To assess the clinical efficacy of intravenous thrombolysis (IT) in patients with cardioembolic (CE) stroke compared to non-cardioembolic (NCE) stroke.

Main Methods:

  • A cohort of 177 patients undergoing IT was retrospectively analyzed.
  • Patients were categorized into CE and NCE groups.
  • Clinical outcomes were evaluated using the National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS).

Main Results:

  • Mean NIHSS scores at admission, 24 hours, and discharge were similar between CE and NCE groups.
  • The reduction in NIHSS from admission to 24 hours and discharge did not significantly differ between the CE and NCE subgroups.
  • Modified Rankin Scale scores at discharge and 3 months showed no significant difference between subtypes, though NCE patients trended towards greater independence at 3 months.

Conclusions:

  • The study findings do not support a specific benefit of IT in cardioembolic stroke.
  • The heterogeneity within the non-cardioembolic (NCE) group might influence outcomes.
  • Further research is needed to clarify the role of IT in different stroke etiologies.
Abstract

More Related Videos

Prehospital Thrombolysis: A Manual from Berlin05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...